weight loss glp 1 injections GLP-1 Options Decoding GLP-1 Weight Loss Medications

The incidence varies considerably between different medications and doses: Semaglutide (Ozempic): Vomiting occurs in approximately 5-10% of patients at diabetes doses Semaglutide (Wegovy): At the higher weight management dose (2.4mg), vomiting affects up to 16% of patients Liraglutide (Victoza): Vomiting affects approximately 5% of patients Liraglutide (Saxenda): At weight management doses, vomiting occurs in about 7-10% of patients Dulaglutide (Trulicity): Vomiting affects approximately 7-9% of patients Tirzepatide (Mounjaro): Vomiting occurs in approximately 5-10% of patients, varying by dose These side effects are most pronounced during the initial treatment phase, particularly in the first 48 weeks, and often diminish as the body adapts to the medication

However, while these drugs have a place in the fight against obesity, metabolic (bariatric) surgery remains the most effective, long-term solution for severe obesity and metabolic diseases

To meet the demand, health providers like Hims & Hers had jumped on the opportunity to provide compounded versions of the weight-loss medications, which haven't been on the market long enough to have generic equivalents

Neutralizes Free Radicals Free radicals are unstable elements that occur due to harmful external and internal factors, including pollution, UV radiation, stress, and poor nutrition

The degree of weight loss depends on factors such as starting body weight, appetite response, dose tolerance, adherence, and lifestyle integration rather than the medication alone